TSX:IN OTCQX:IMLFF VANCOUVER, Sept. 10, 2018 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary biosynthesis platform technology to develop novel...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]nthesis-program-300708576.html